Sheila Scully

Active 1990–2006

36
Papers
19,287
Citations
36
h-index
36
i10-index

Citations

Citations per year for Sheila Scully1980: 1 citations1986: 1 citations1990: 1 citations1992: 3 citations1993: 1 citations1994: 1 citations1995: 2 citations1997: 6 citations1998: 56 citations1999: 199 citations2000: 316 citations2001: 400 citations2002: 398 citations2003: 416 citations2004: 358 citations2005: 364 citations2006: 338 citations2007: 277 citations2008: 279 citations2009: 256 citations2010: 229 citations2011: 235 citations2012: 173 citations2013: 160 citations2014: 111 citations2015: 91 citations2016: 107 citations2017: 96 citations2018: 88 citations2019: 315 citations2020: 302 citations2021: 250 citations2022: 187 citations2023: 111 citations2024: 159 citations2025: 78 citations2026: 3 citations1981–1985: no citations, so these years are not shown1987–1989: no citations, so these years are not shown1991: no citations, so this year is not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,376 citing papers, 33.9% of this breakdownJapan: 599 citing papers, 8.5% of this breakdownUnited Kingdom: 485 citing papers, 6.9% of this breakdownChina: 469 citing papers, 6.7% of this breakdownGermany: 360 citing papers, 5.1% of this breakdownCanada: 289 citing papers, 4.1% of this breakdownAustralia: 270 citing papers, 3.9% of this breakdownFrance: 218 citing papers, 3.1% of this breakdownItaly: 199 citing papers, 2.8% of this breakdownSwitzerland: 151 citing papers, 2.2% of this breakdownSouth Korea: 145 citing papers, 2.1% of this breakdownNetherlands: 145 citing papers, 2.1% of this breakdown
0%33.9%Other 18.6%

Fields

  • Biochemistry, Genetics and Molecular Biology49.2%
  • Medicine31.9%
  • Neuroscience8.5%
  • Immunology and Microbiology7%
  • Dentistry1.2%
  • Nursing0.7%
  • Other1.5%

Topics

  • Bone Metabolism and Diseases12.4%
  • Bone health and treatments8.5%
  • Bone health and osteoporosis research3.8%
  • NF-κB Signaling Pathways2.8%
  • Regulation of Appetite and Obesity2.2%
  • Parathyroid Disorders and Treatments1.6%
  • Other68.7%

Coauthors

All papers

Open in search
  1. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cell 1998 cited by 5,471

  2. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

    Authors: , , , , , , , , , , , - Genes & Development 1998 cited by 2,480

  3. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

    Authors: , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 1,639

  4. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

    Authors: , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 1,127

  5. The Osteoclast Differentiation Factor Osteoprotegerin-Ligand Is Essential for Mammary Gland Development

    Authors: , , , , , , , , , , , , - Cell 2000 cited by 753

  6. T-cell co-stimulation through B7RP-1 and ICOS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 1999 cited by 768

  7. Dll4, a novel Notch ligand expressed in arterial endothelium

    Authors: , , , , , , , - Genes & Development 2000 cited by 522

  8. Pharmacodynamics of the Type II Calcimimetic Compound Cinacalcet HCl

    Authors: , , , , , , , , , , , , , , , - Journal of Pharmacology and Experimental Therapeutics 2004 cited by 366

  9. CSMD1 Is a Novel Multiple Domain Complement-Regulatory Protein Highly Expressed in the Central Nervous System and Epithelial Tissues

    Authors: , , , , , , , , , - The Journal of Immunology 2006 cited by 217

  10. Murine homolog ofSALL1is essential for ureteric bud invasion in kidney development

    Authors: , , , , , , , , , , , , - Development 2001 cited by 360

  11. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen A. Kaufman, James K. Pretorius, Sheila Scully, Russ Cattley, Marc Payton, Steve Coats, Linh T. Nguyen, Binodh DeSilva, Anthony Ndifor, Isaac J. Hayward, Robert Radinsky, T. Boone, Richard Kendall - Cancer Cell 2004 cited by 469

  12. Novel neurotrophin-1/B cell-stimulating factor-3: A cytokine of the IL-6 family

    Authors: , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 249

  13. Transferrin Is an Essential Factor for Myelination

    Authors: , , , , , , , , - Neurochemical Research 1999 cited by 92

  14. Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless

    Authors: , , , , , , , - Genes & Development 1998 cited by 887

  15. Osteoprotegerin Reverses Osteoporosis by Inhibiting Endosteal Osteoclasts and Prevents Vascular Calcification by Blocking a Process Resembling Osteoclastogenesis

    Authors: , , , , , , , , , , , - The Journal of Experimental Medicine 2000 cited by 559

  16. FGF-18, a Novel Member of the Fibroblast Growth Factor Family, Stimulates Hepatic and Intestinal Proliferation

    Authors: , , , , , , , , , , , - Molecular and Cellular Biology 1998 cited by 151

  17. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice.

    Authors: , , , , , - Genes & Development 1997 cited by 671

  18. IL-18-Binding Protein Protects Against Lipopolysaccharide- Induced Lethality and Prevents the Development of Fas/Fas Ligand-Mediated Models of Liver Disease in Mice

    Authors: , , , , , , , , , , , , , , , , , , - The Journal of Immunology 2001 cited by 116

  19. Osteoprotegerin Ligand Modulates Murine Osteoclast Survival in Vitro and in Vivo

    Authors: , , , , , , , , , , , , , - American Journal Of Pathology 2000 cited by 396

  20. Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production

    Authors: , , , , , , , , , , , , , , , , , - Blood 2002 cited by 188

  21. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors

    Authors: , , , , , , , , - Journal of Cellular Biochemistry 1999 cited by 124

  22. The effects of keratinocyte growth factor in preclinical models of mucositis

    Authors: , , , , , , , , - Cell Proliferation 2002 cited by 109

  23. Differential Effects of Leptin in Regulation of Tissue Glucose Utilization in Vivo*

    Authors: , , , , - Endocrinology 1999 cited by 102

  24. Morphologic and molecular changes induced by recombinant human leptin in the white and brown adipose tissues of C57BL/6 mice.

    Authors: , , , , , , - 1997 cited by 98